A specific and sensttive Sandwich enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of apolipoprotein C-III, a major apolipoprotein of human very low density lipoproteins is described. The assay is non-competitive and it uses the same affinity isolated sheep antibody both for coating the wells and as conjugate with alkaline phosphatase. Total serum apo C-III was determined in a normal population of 24 men and 21 women. The difference was not statistically significant. In both sexes apo C-II1 concentration correlated positively with the serum triglyceride levels. In patients with hyperlipoproteinernia , apo C-II1 levels were increased.
shown to result in hypertriglyceridaemia." The physiological importance of apo C-I and apo C-III is not yet fully understood. Apo C-lll seems to prevent the hepatic uptake of triglyceriderich lipoproteins": 'i and under certain experimental conditions it is capable of inhibiting lipoprotein lipase. Ill. II The present report describes the development of an enzyme-linked immunosorbent assay (ELISA) for the quantitation of apo C-III. This assay has been used to characterise the relationship of apo C-lll levels to lipid levels by assessing C-III levels in normal donors and in patients with different types of hyperlipoproteinaernia.
Materials and methods

SERUM SAMPLES
Blood samples were taken after an overnight fast and centrifuged. Serum samples were either stored at 4°C and analysed within 2 weeks, or frozen at -20°e. LIPID 
ANALYSES
Cholesterol and triglycerides were measured enzymatically in a Technicon AA-II analyser, using reagents from Technicon Instruments Corp. (Tarrytown, NY, USA). PREPARATION OF LIPOPROTEIN DENSITY FRACTIONS VLDL and LDL were precipitated from a plasma pool of six blood donors with Naphosphotungstate (0·4'Yo w/v) and MgCl 2 (0·05 mol/L) according to Burstein, Scholnick and Morfin;'? The supernatant was further processed for the HDL preparation as described by the same authors.U The precipitate was washed with the precipitating agent and dissolved in 0·2 M Na-citrate , pH 8·6. VLDL and LDL were separated by ultracentrifugation at d= H)llJ g/rnl., with 110000 g for 23 h. The top represented VLDL, the infranatant was adjusted to d= [·063 g/mL and centrifuged at the same conditions. For the preparation of HDL, the gammaglobulins were precipitated by addition of Na-phosphotungstate (4% w/v). The final concentration of Na-phosphotungstate was 2% w/v, that of MgCl z 0·025 mol/L (due to dilution). HDL was then precipitated by addition of a solution of MgCI 2 (2 mol/L) to a final MgCl, concentration of 0·2 mol/L. The final Naphosphotungstate concentration was 1·84% w/v. The precipitate was dissolved in NazCO] (10°;', w/v), and centrifuged in the ultracentrifuge at d=I·21 g/mL.
ISOLATION OF APO C-III AND PRODUCTION
OF ANTI-C-III ANTIBODIES In order to remove any salts, VLDL was dialysed against distilled HzO, adjusted to pH l)·5, with NH 40H (25% w/v), lyophilised and lipids extracted at 4°C with ether (five times), followed by ether-ethanol (3: 1 vlv , five times, last time overnight) and washed several times with ether. I]. 14 The residue was dissolved in 6 mol/L urea, (J.(JI mol/L Tris HCl, pH 8·6, and apo C-lII was isolated from apo VLDL by gel filtration on a column (2·5 crn x 1·5 ern) of Sephacryl S-200 superfine™ in 6 mol/L urea, 1)-01 mol/L Tris HCI, pH 8·6. The peak containing apo C-lII was further purified by preparative isoelectric focusing on Ultrodex (LKB, Brornma, Swedenj.!" Apo C-llI was checked for purity by analytical isoelectric focusing, SDS polyacrylamide gel electrophoresis and double immunodiffusion against anti-apo Band anti-Bj-glycoprotein-I (Behringwerke AO, Marburg/Lahn, FRO), anti-ape A-I and antiapo A_II,lr, anti-apo C-I, anti-ape C-II and anti-apo E (Riesen and Sturzenegger, unpublished observations). Sheep were irnrnunised with 1 mg of apo C-lII in complete Freund's adjuvant and boosted at bi-weekly intervals with the same amount of apo C-lli in incom-plete Freund's adjuvant. Blood was taken the first time after 2 weeks and then at bi-weekly intervals. Anti-apo C-I1I antibodies were isolated by immunoadsorption on apo-C-III-Sepharose 4B. The anti-apo C-I1I titre determined by this isolation procedure was in the range of 200 ug/rnl.. This was found to decrease with further boosting.
QUANTITATION OF APO C-III BY ELISA
Purified anti-apo C-II1 (300 Ilg/80 ul.) was conjugated with alkaline phosphatase (700 Ilg/ 70 ut., Boehringer Mannheim, FRO) according to standard techniques. 17-18. 19 Separation of conjugated and non-conjugated fractions was achieved by gel filtration of SephacrylP' S-300 in Tris uci, 0·05 M, pH 8·0, containing NaCl 0·1 mrnol/L, MgCl 2 0·1 mmol/L and NaNO] 0·1% (w/v).
For coating of the solid phase, purified anti-apo C-III at a concentration of 5 Ilgl200 IJ.L of coating buffer per well (Dynatech Micro Eliza MI29 B™ microtitre plates) was taken. Coating buffer consisted of 1·59 g Na 2CO], 2,93 g NaHCO], 0·1 g NaN] made up to 11 with distilled H 20, final pH l)·6. This buffer was stored at 4 Q C and used within 2 weeks. Coating conditions were 37 Q C for 3 h, followed by 4 QC overnight (plates were covered). Subsequently, the plates were washed three times with PBS-Tween 20 (0·05%), pH 7·4. Before use, the plates were saturated by means of 200 IJ.Uwell of a solution of 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) pH 7·4. Subsequently this was washed off with PBS-Tween. Optimal conditions for the ELISA were found to be the following: Two hundred microlitres of standard (1,15 IJ.glmL-3 nglmL) or serum in duplicate, diluted 5000-fold with PBS-Tween were pipetted into the wells of a pre-coated microtitre plate. The covered plates were incubated for 2 h at room temperature and washed five times with PBS-Tween. Two hundred microlitres of anti-apo C-III enzyme conjugate, diluted 30 times with the same buffer, were added per well and the plates were incubated for 2 h at room temperature. Thereafter, the plates were washed five times with PBS-Tween and incubated with p-nitrophenylphosphate (1 mg/ml.), 200 IJ.L/well until absorbance was approximately 1·2 for the highest concentration of the standard. p-Nitrophenylphosphate was always freshly dissolved in 2·226 giL Na 2CO], 2·436 giL NaHCO], 0·203 giL MgCl 2 and for Precinorm™ an apo ClII concentration of 0·05 giL was found. A high specificity of the assay is indicated by the low cross-reaction with the various protein fractions assessed. It was found to be 0% for human serum albumin. 0·11'}/0 for apo A-I, 2·4'X, for apo A-II. 0% for Brglycoprotein-I, 0·7%, for apo E, O·l'}/u for apo C-I and 2·3°/<, for apo C-II. For LDL a cross-reaction of 0-4'1., was observed, for apo VLDL 30·4%, and for apo HDL 2%. The precision of the assay was satisfactory. as illustrated in Table I . The recoveries obtained by the ELISA technique after addition of isolated apolipoprotein C-III in known concentrations to a normal serum and to a type V hyperlipaemic serum are given in Table 2 . The recoveries corresponded to the precision of the assay, indicating a satisfactory accuracy of the test. § Fig. 1 .
The standard curves were constructed with apo C-III, VLDL, LDL, HDL, as illustrated in Fig. 2 . The linear range was from 80·0 ng to 5·0 ng. The concentration of the Omega™ control serum was 0·095 gIL, the Roche™ control serum had a concentration of 0·220 giL Results and the developed colour was read at 405 nm in a Dynatech micro ELISA reader.
Omega™ Lipid Fraction control serum (Hyland Diagnostics, Deerfield, II 60015, USA) and Lipid Control Roche" (Hoffman-La Roche AG, Basel, Switzerland) were used as control sera; PrecinormTM (Boehringer Mannheim, FRG) was used as a secondary standard, since isolated apo C-III proved to be unstable in solution. Standard curves were obtained by plotting absorbance at 405 nm as a function of the logarithmic apo C-III concentration. Results were calculated by legit-log transformation on a programmable Hewlett-Packard calculator HP 97. 
Apo C-IlI
Intra-assay Inter-assay concentration CV ('Yo) CV ('X,) (giL) (n= 10) (n= 10)
apo C-III in normal male and female subjects. Both groups had a similar mean age (men: 52±17, women: 50±20 years). Women were found to have a slightly higher concentration of apo C-III as compared to men with similar triglyceride levels. However, this difference was not statistically significant. In both sexes a high correlation between the concentration of apo C-Ill and the level of the triglycerides was noted. In contrast, the level of total serum cholesterol did not correlate with the apo C-Ill concentration.
In order to study the influence of storage on the concentration of apo C-IlI, serum samples stored for 2-3 months at -2()OC (n= 14) and serum samples stored for up to 4 years with repeated freezing and thawing (n=29) were assessed. All groups of serum samples had similar levels of triglycerides. Serum samples which were stored for 2-3 months showed a TABl.E 2. Accuracy of the ELISA for apo C-Ill mean increase in apo C-Ill of 8%, and serum samples stored for more than I year exhibited a mean increase of approximately 25%.
Delipidation with tetra-methyl-urea (l: I , v/v) did not increase the apparent concentration of apo C-Ill.
APO C-III LEVELS IN HYPER LI POPROTEI N A EM I A
The levels of apo C-III in the different types of hyperlipoproteinaemia and their correlation to the concentration of triglycerides and cholesterol are summarised in Table 4 . In Type I and in Type V hyperlipoprotcinaernia , serum samples which were stored for at least 1 year had to be employed. In the other types it was possible to analyse fresh serum samples. The highest concentration of apo C-III was observed in Type V hyperlipoproteinaemia. This type also showed the highest triglyceride (l67  1·7±0·6  H·9±1·5  0·11  O·IH  IIb  21  0·295±0·1U3  3·3±0·9  H·7±1·0  0·64  0·30  III  I  0·49H  11·6  IH·O  IV  25  O·366±0·100  6·2±2·3  7·7±1·7  0·4H  0·40  V  12  0·650±0·290  19·5+12·7  13·5±5·0  0·26  0·19 levels. However, the correlation between apo C-III and triglycerides was almost as low as in Type IIa hyperlipoproteinaernia, in which the lowest apo C-III levels were noted. The highest correlation between apo C-III and triglycerides was found in Type I hyperlipoproteinaemia (r=0·70). It is noteworthy that in this type, apo C-III levels correlated even better with the cholesterol concentration (r=0'87) , while in the other types the correlation between apo C-III and cholesterol was between 0·18 and llAO.
Discussion
In this report we describe an enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of apo C-III in serum and in isolated lipoprotein fractions. The results obtained with this assay show good precision and a high sensitivity and they are in good agreement with data published by other authors, using different techniques, such as radioirnmunoassay.i'': 21 electroimmunodiffusion.V or imrnunonephelometry.P A competitive ELISA for apo C-III, previously publishedr" was performed with enzyme-conjugated VLDL, because the apolipoproteins C-I, C-II and C-III lost their reactivity with the appropriate antibodies upon conjugation to enzyme. Our assay is non-competitive and it uses the same antibody for coating and as enzyme conjugate as previously published by Parsy et al. 25 The ELISA offers some advantages over the previously employed techniques. It does not depend on a standard having the same migration properties as are crucial for electroimmunodiffusion, nor is it sensitive to the turbidity occurring in serum samples with a high triglyceride concentration such as immunonephelometry. In contrast to radio labelled compounds, the enzyme conjugate is stable for several months.
In this study the levels of apo C-III in normal serum samples and in serum samples from patients with different types of hyperlipoproteinaemia was examined. In addition, the influence of the sex and the influence of storage on the apo C-III values were studied.
VLDL, which are the major source of apo C-III, are made up by rather large molecules, consisting for the major part of lipids, notably endogenous triglycerides, which might hide antigenic binding sites on the proteins. Indeed, we observed an increase in apo C-III in serum samples stored over several months with repeated freezing and thawing, which might be explained by a breakdown of the native conformation leading to C-III molecules more accessible for the antibodies. Similar observations have already been made for apo A-I, which also shows a higher concentration after storage than in the native state.I" However, delipidation with tetra-methylurea according to Kane et al. 27 for full exposure of the antigenic sites did not increase the apparent concentration of apo CIII. Presently, we do not yet know whether this procedure decreases the reactivity of apo C-III with its antibody, thus leading to apparently lower concentrations.
So far, the influence of the sex on the level of apo C-III has not yet been investigated. A sexrelated difference has previously been described for apo A-I. 2H. 29 The level of apo A-I was notably increased in women taking oral contraceptives. Since exogenous oestrogens not only have an influence on HDL and its apoproteins, but also on triglycerides.?" and consequently on VLDL, which contain the major part of plasma apo C-III, one might expect different levels for apo C-III in women and in men. In our group of apparently healthy men and women of similar age, no significant difference in the apo C-III concentration could be observed, although women showed about 15'Yo higher values than men.
As expected, the major part of apo C-III was found in the VLDL, while LDL and HDL contained only minor amounts. No apo C-III was detected in the infranatant after separation of HDL. This indicates a rather strong interaction between apo C-III and lipids or eventually other proteins in the lipoprotein complex, allowing no free apo C-III in circulation. Significant amounts of free apolipoproteins in plasma were detected in the case of apo E]1 and apo H (Bj-glycoprotein-Ij.V Increased apo C-1I1 levels were observed in all types of hyperlipoproteinaernia , even in the pure hypercholesterolaemia (Type IIa). The highest apo C-III concentration was found in Type V hyperlipoproteinaernia, where the highest increase in triglycerides occurred. Surprisingly, in this type of hyperlipoproteinaernia, apo C-III levels did not correlate with triglycerides, while in Type I hyperlipoproteinaemia a strong correlation was not only found between apo C-III and triglycerides but also between apo C-III and total cholesterol. It is noteworthy that in normal serum samples a stronger correlation was observed between apo C-III and triglyceride values than in hypertriglyceridaemic serum samples, except for Type I hyperlipoprotein-aemia. Whether this finding is due to an abnormal composition of VLDL in Type IV and Type V hyperlipoproteinaemia remains to be determined. Further studies on apo C-1I1 levels and on its distribution within the various lipoprotein density fractions in normal and in hyperlipaemic serum samples are needed in order to provide a deeper insight into the potential physiological role of this apolipoprotein.
